Rapid Micro Biosystems Hits New 52-Week Low at $1.88

Rapid Micro Biosystems, Inc., a microcap company in the industrial manufacturing sector, has reached a new 52-week low of USD 1.88 as of May 27, 2026. This significant decline highlights the stock's recent struggles, particularly in contrast to its 52-week high of USD 4.94. Over the past year, Rapid Micro Biosystems has experienced a performance drop of 18.22%, which starkly contrasts with the S&P 500's return of 11.87% during the same period. Despite a reported increase in profits of 8.5%, the stock's overall performance has not aligned with broader market trends, indicating a challenging environment for the company. With a market capitalization of USD 132 million, Rapid Micro Biosystems operates in a competitive landscape, and its financial metrics reflect a loss-making position, as evidenced by a negative return on equity of 99.91%. The company's price-to-book ratio stands at 2.97, further illustrating its current valuation challenges. As the stock continues to navigate these dynamics, its recent low may prompt further scrutiny from market participants.